Package 42291-261-30

Brand: entecavir

Generic: entecavir
NDC Package

Package Facts

Identity

Package NDC 42291-261-30
Digits Only 4229126130
Product NDC 42291-261
Product ID 42291-261_485b9c2c-4461-5cf2-e063-6394a90a625c
Description

30 TABLET, FILM COATED in 1 BOTTLE (42291-261-30)

Marketing

Marketing Status
Marketed Since 2020-11-02
Brand entecavir
Generic entecavir
Sample Package No

Linked Drug Pages (1)

Entecavir ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "485b9c2c-4461-5cf2-e063-6394a90a625c", "openfda": {"unii": ["5968Y6H45M"], "rxcui": ["485434", "485436"], "spl_set_id": ["5a1cbf7e-0352-aa3b-080c-222a6423ecd8"], "manufacturer_name": ["AvKARE"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (42291-261-30)", "package_ndc": "42291-261-30", "marketing_start_date": "20201102"}], "brand_name": "Entecavir", "product_id": "42291-261_485b9c2c-4461-5cf2-e063-6394a90a625c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Analog [EXT]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "42291-261", "generic_name": "Entecavir", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Entecavir", "active_ingredients": [{"name": "ENTECAVIR", "strength": ".5 mg/1"}], "application_number": "ANDA206652", "marketing_category": "ANDA", "marketing_start_date": "20201102", "listing_expiration_date": "20271231"}